The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to ...

Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...

Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss the approval of a GLP-1 pill for weight ...

Oprah Winfrey opens up about her weight loss journey, GLP-1 medication, and the lessons she learned about obesity, self-blame ...

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

Indian pharma major Lupin Limited announced that it has entered into an exclusive license, supply and distribution agreement ...

The human body naturally makes a hormone called GLP-1, or Glucagon-Like Peptide-1. It helps signal fullness and stimulate insulin secretion in the body. GLP-1 drugs do something similar – but they ...

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving ...

New research reveals that taking a GLP-1 can be equivalent to '10 years of ageing' on the body, if proper precautions aren't ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

Port Edwards, Wis. (WSAW) - A Port Edwards man is awaiting a life or death heart transplant. The only reason he’s even able to wait for one, is because of GLP-1 medication. Doctors said if he wanted a ...